Growth Metrics

Cytosorbents (CTSO) Free Cash Flow (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 76.22%
Dec 31, 2025 -90.17%
Sep 30, 2025 -67.79%
Jun 30, 2025 55.42%
Mar 31, 2025 -43.90%
Dec 31, 2024 7.84%
Sep 30, 2024 45.66%
Jun 30, 2024 1.29%
Mar 31, 2024 25.03%
Dec 31, 2023 -21.58%
Sep 30, 2023 26.06%
Jun 30, 2023 -132.72%
Mar 31, 2023 72.12%
Dec 31, 2022 -525.76%
Sep 30, 2022 84.01%
Jun 30, 2022 -8.62%
Mar 31, 2022 -12.28%
Dec 31, 2021 -213.17%
Sep 30, 2021 -3.24%
Jun 30, 2021 -1.87%
Mar 31, 2021 -127.32%
Dec 31, 2020 65.29%
Sep 30, 2020 -289.22%
Jun 30, 2020 153.91%
Mar 31, 2020 19.23%
Dec 31, 2019 20.05%
Sep 30, 2019 -60.32%
Jun 30, 2019 26.55%
Mar 31, 2019 -57.10%
Dec 31, 2018 -8.30%
Sep 30, 2018 24.32%
Jun 30, 2018 -43.81%
Mar 31, 2018 -198.31%
Dec 31, 2017 67.63%
Sep 30, 2017 -24.07%
Jun 30, 2017 0.65%
Mar 31, 2017 -93.16%
Dec 31, 2016 57.87%
Sep 30, 2016 -27.24%
Jun 30, 2016 -53.06%
Mar 31, 2016 44.40%
Dec 31, 2015 1.45%
Sep 30, 2015 11.91%
Jun 30, 2015 -30.16%
Mar 31, 2015 4.23%
Dec 31, 2014 -9.83%
Sep 30, 2014 -31.37%
Jun 30, 2014 -81.87%
Mar 31, 2014 25.85%
Dec 31, 2013 -96.32%
Sep 30, 2013 45.95%
Jun 30, 2013 -28.64%
Mar 31, 2013 -3.83%
Dec 31, 2012 -23.16%
Sep 30, 2012 44.64%
Jun 30, 2012 -6.91%
Mar 31, 2012 3.35%
Dec 31, 2011 0.59%
Sep 30, 2011 -8.08%
Jun 30, 2011 -75.63%
Mar 31, 2011 12.01%
Dec 31, 2010 -5.30%